Geographically Targeted Interventions versus Mass Drug Administration to Control Taenia solium Cysticercosis, Peru
Seth E. O’Neal
, Ian W. Pray, Percy Vilchez, Ricardo Gamboa, Claudio Muro, Luz Maria Moyano, Viterbo Ayvar, Cesar M. Gavidia, Robert H. Gilman, Armando E. Gonzalez, Hector H. Garcia, and
for the Cysticercosis Working Group in Peru
Author affiliations: Oregon Health & Science University–Portland State University School of Public Health, Portland, Oregon, USA (S.E. O’Neal, I.W. Pray); Universidad Peruana Cayetano Heredia, Lima, Peru (S.E. O’Neal, P. Vilchez, R. Gamboa, C. Muro, L.M. Moyano, H.H. Garcia); Universidad Nacional Mayor de San Marcos, Lima (V. Ayvar, C.M. Gavidia, A.E. Gonzalez); Johns Hopkins University, Baltimore, Maryland, USA. (R.H. Gilman)
Main Article
Figure 3
Figure 3. Timeline showing interventions in humans and pigs during a study of Taenia solium tapeworms, Peru. NSMm, presumptive treatment with niclosamide for humans; NA, not applicable; NSMr, presumptive treatment with niclosamide for humans only in rings; OXFm, presumptive treatment with oxfendazole for pigs; OXFr, presumptive treatment with oxfendazole for pigs only in rings; SCRr/NSMr, stool screening and treatment with niclosamide for humans with diagnosed taeniasis only in rings.
Main Article
Page created: June 28, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.